Response Genetics Signs Contract with BCBS of Illinois | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics today announced the execution of a provider contract with Blue Cross and Blue Shield of Illinois, providing the health plan's 7.4 million members coverage for the Los Angeles-based molecular diagnostics firm's tests.

Response Genetics offers molecular predictive tests for lung, colon, gastric, and melanoma cancers, as well as tests for detecting EGFR, KRAS, and other mutations. Its tests, the firm said, help physicians determine which treatments may be best for each individual patient.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.